Clay Thorp Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Clay Thorp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Clay Thorp. Clay Thorp is Director in PhaseBio Pharmaceuticals Inc ($PHAS) and Director in Clearside Biomedical, Inc. ($CLSD) and 10% Owner in G1 Therapeutics, Inc. ($GTHX).

Latest Insider Trading Transactions of Clay Thorp

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLSD, GTHX, PHAS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 04 2021	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	3.53	14,000	49,420	14,000
Feb 12 2021	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	4.43	32,873	145,627	3,433,521	3.5 M to 3.4 M (-0.95 %)
Jun 19 2020	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	A	2.00	25,000	50,000	25,000
Jun 05 2020	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	4.86	16,000	77,760	16,000
Nov 26 2019	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Grant	A	1.05	1,518,026	1,599,999	4,984,420	3.5 M to 5 M (+43.79 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	459	6,426	415,959	416.4 K to 416 K (-0.11 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	255	3,570	52,397	52.7 K to 52.4 K (-0.48 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	180	2,520	162,890	163.1 K to 162.9 K (-0.11 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	2,014	28,196	1,818,638	1.8 M to 1.8 M (-0.11 %)
Jun 24 2019	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	A	1.07	20,000	21,400	20,000
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	63	882	416,418	416.5 K to 416.4 K (-0.02 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	35	490	52,655	52.7 K to 52.7 K (-0.07 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	25	350	163,074	163.1 K to 163.1 K (-0.02 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	277	3,878	1,820,656	1.8 M to 1.8 M (-0.02 %)
May 13 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	13.23	11,000	145,530	11,000
Mar 01 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	3.15	36,000	113,400	36,000
Dec 06 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Buy	P	1.36	8,000	10,880	8,000	0 to 8 K
Dec 06 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	3.13	4,000	12,520	15,799	11.8 K to 15.8 K (+33.90 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	226,061	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	24,709	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	272,107	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	40,420	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,558	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	149,320	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	94,874	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	1,044,764	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,609	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	174,699	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	4,846	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	3,862	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	42,530	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	52,690	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	994	0	40,420
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	41,414	0	41,414
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	41,414	4,970	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	104	0	13,558
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	4,309	0	13,662
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	4,309	517	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	1,139	0	149,320
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	47,458	0	150,459
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	47,458	5,695	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	42	0	94,874
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	1,731	0	94,916
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	1,731	208	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	458	0	1,044,764
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	19,061	0	1,045,222
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	19,061	2,287	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	150,000	750,000	416,481	266.5 K to 416.5 K (+56.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	266,481	0	266,481	0 to 266.5 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	4,846	0	4,846	0 to 4.8 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	12,487	62,435	163,099	150.6 K to 163.1 K (+8.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	150,612	0	150,612	0 to 150.6 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	137,513	687,565	1,820,933	1.7 M to 1.8 M (+8.17 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	1,683,420	0	1,683,420	0 to 1.7 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	52,690	0	52,690	0 to 52.7 K
Jun 21 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	A	10.74	11,250	120,825	11,250
Jun 01 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	48.00	41,710	2,002,080	3,237,711	3.3 M to 3.2 M (-1.27 %)
Jun 01 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	48.00	758,290	36,397,920	3,279,421	4 M to 3.3 M (-18.78 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	50.50	26	1,313	4,037,711	4 M to 4 M (0.00 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	50.50	474	23,937	4,037,737	4 M to 4 M (-0.01 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	50.69	308	15,611	4,038,211	4 M to 4 M (-0.01 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	50.86	5,592	284,405	4,038,519	4 M to 4 M (-0.14 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	52.13	26	1,355	4,044,111	4 M to 4 M (0.00 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	52.13	474	24,710	4,044,137	4 M to 4 M (-0.01 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	51.06	1,595	81,439	4,044,611	4 M to 4 M (-0.04 %)
May 23 2018	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	S	51.16	29,005	1,483,907	4,046,206	4.1 M to 4 M (-0.71 %)
May 21 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	13.16	61,139	804,589	3,466,394	3.5 M to 3.5 M (-1.73 %)
May 21 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	13.03	100,000	1,303,000	3,527,533	3.6 M to 3.5 M (-2.76 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.02	5,231	62,877	3,627,533	3.6 M to 3.6 M (-0.14 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.02	5,231	62,877	3,627,533	3.6 M to 3.6 M (-0.14 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.07	33,630	405,914	3,632,764	3.7 M to 3.6 M (-0.92 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.07	33,630	405,914	3,632,764	3.7 M to 3.6 M (-0.92 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.27	100,000	1,227,000	3,666,394	3.8 M to 3.7 M (-2.66 %)
Mar 23 2018	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	12.27	100,000	1,227,000	3,666,394	3.8 M to 3.7 M (-2.66 %)
Dec 07 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.13	5,000	30,650	3,766,394	3.8 M to 3.8 M (-0.13 %)
Dec 07 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.09	15,000	91,350	3,771,394	3.8 M to 3.8 M (-0.40 %)
Dec 07 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.37	15,000	95,550	3,786,394	3.8 M to 3.8 M (-0.39 %)
Dec 04 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Buy	J	0.00	995	0	4,075,211	4.1 M to 4.1 M (+0.02 %)
Dec 04 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Sell	J	0.00	99,513	0	4,074,216	4.2 M to 4.1 M (-2.38 %)
Nov 16 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.99	5,000	34,950	3,801,394	3.8 M to 3.8 M (-0.13 %)
Nov 16 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.99	15,000	104,850	3,806,394	3.8 M to 3.8 M (-0.39 %)
Nov 16 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.02	15,000	105,300	3,821,394	3.8 M to 3.8 M (-0.39 %)
Oct 05 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.34	6,000	50,040	3,836,394	3.8 M to 3.8 M (-0.16 %)
Oct 05 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.59	14,000	120,260	3,842,394	3.9 M to 3.8 M (-0.36 %)
Oct 05 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.64	15,000	129,600	3,856,394	3.9 M to 3.9 M (-0.39 %)
Sep 15 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.54	10,000	75,400	3,871,394	3.9 M to 3.9 M (-0.26 %)
Sep 15 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.52	6,000	45,120	3,881,394	3.9 M to 3.9 M (-0.15 %)
Sep 15 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.49	8,500	63,665	3,887,394	3.9 M to 3.9 M (-0.22 %)
Aug 09 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.30	15,000	109,500	3,895,894	3.9 M to 3.9 M (-0.38 %)
Aug 09 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.98	5,000	39,900	3,910,894	3.9 M to 3.9 M (-0.13 %)
Aug 09 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.02	4,500	36,090	3,915,894	3.9 M to 3.9 M (-0.11 %)
Jun 23 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	A	8.81	8,618	75,925	8,618
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Option Exercise	C	0.00	1,009,693	0	0
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Option Exercise	C	0.00	2,584,959	0	0
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Option Exercise	C	0.00	6,568,527	0	0
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Option Exercise	C	0.00	1,318,681	0	0
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Buy	P	15.00	133,333	1,999,995	3,861,797	3.7 M to 3.9 M (+3.58 %)
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Buy	C	0.00	99,513	0	99,513	0 to 99.5 K
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Buy	C	0.00	212,419	0	212,419	0 to 212.4 K
May 24 2017	GTHX	G1 Therapeutics, I ...	Thorp Clay	10% Owner	Buy	C	0.00	3,728,464	0	3,728,464	0 to 3.7 M
May 19 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.31	15,000	124,650	3,920,394	3.9 M to 3.9 M (-0.38 %)
May 19 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.44	9,000	75,960	3,935,394	3.9 M to 3.9 M (-0.23 %)
May 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.39	19,000	159,410	3,944,394	4 M to 3.9 M (-0.48 %)
May 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.61	9,544	82,174	3,963,394	4 M to 4 M (-0.24 %)
May 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.94	15,941	142,513	3,972,938	4 M to 4 M (-0.40 %)
Apr 19 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.37	2,030	14,961	3,988,879	4 M to 4 M (-0.05 %)
Apr 19 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.48	44,455	332,523	3,990,909	4 M to 4 M (-1.10 %)
Apr 19 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.43	22,000	163,460	4,035,364	4.1 M to 4 M (-0.54 %)
Mar 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.77	21,485	145,453	4,057,364	4.1 M to 4.1 M (-0.53 %)
Mar 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	6.47	47,000	304,090	4,078,849	4.1 M to 4.1 M (-1.14 %)
Feb 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.54	10,000	75,400	4,152,849	4.2 M to 4.2 M (-0.24 %)
Feb 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.58	14,000	106,120	4,162,849	4.2 M to 4.2 M (-0.34 %)
Feb 17 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.64	17,485	133,585	4,176,849	4.2 M to 4.2 M (-0.42 %)
Jan 20 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.77	8,000	62,160	4,194,334	4.2 M to 4.2 M (-0.19 %)
Jan 20 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.23	15,485	127,442	4,202,334	4.2 M to 4.2 M (-0.37 %)
Jan 20 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.64	25,000	216,000	4,217,819	4.2 M to 4.2 M (-0.59 %)
Jan 20 2017	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	8.92	20,000	178,400	4,242,819	4.3 M to 4.2 M (-0.47 %)
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	X	0.02	21,705	478	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	X	0.02	1,805	40	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	X	0.02	19,900	438	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	C	0.00	675,795	0	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	C	0.00	865,881	0	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	C	0.00	1,654,531	0	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Option Exercise	C	0.00	4,071,815	0	0
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Buy	P	7.00	785,714	5,499,998	4,262,819	3.5 M to 4.3 M (+22.60 %)
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Sell	S	7.00	138	966	3,477,105	3.5 M to 3.5 M (0.00 %)
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Buy	X	0.02	43,410	955	3,477,243	3.4 M to 3.5 M (+1.26 %)
Jun 07 2016	CLSD	Clearside Biomedic ...	Thorp Clay	Director	Buy	C	0.00	3,321,785	0	3,433,833	112 K to 3.4 M (+2,964.61 %)

Page: 1